KRX-0401 is undergoing clinical trials for its use as treatment for multiple myeloma and multiple other forms of cancer. It has been awarded a fast track designation and orphan drug status by the FDA.
-
KRX-0401 is undergoing clinical trials for its use as treatment for multiple... -
Multiple myeloma is an incurable cancer occurring in the plasma cells. -
In August 2009 Keryx began Phase III trials of KRX-0401 in combination with...
